KLTO (KLTO)
Klotho Neurosciences, Inc.
NASDAQ:KLTOHealthcare · Biotechnology
Mkt Cap-
Float63.98M
O/S-
Inst Own-
Dilution
Delisting Issues Timeline
Financials Summary
Revenue$0
Net Income-$10.55M
Total Assets$9.59M
Free Cash Flow-$5.86M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$9.46M
Shares Outstanding
Short Interest
Split History
No splits on record
Nothing in KLTO's public trading history: no forward or reverse split has affected the share count.
Balance Sheet Details
Assets$9.59M
Liabilities$130K
Accounts Receivable$0
Accounts Payable$0
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$2.3M
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 | $0 |
| Gross Margin | - | - | - | - | - |
| Research and Development | $634K | $0 | $0 | $0 | $0 |
| Selling, General, and Administrative | $6.51M | $5.54M | $631K | $574K | $1.11M |
| Other | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $7.15M | $5.54M | $631K | $574K | $1.11M |
| Operating Income (EBIT) | -$7.15M | -$5.54M | -$631K | -$574K | -$1.11M |
| Operating Margin | - | - | - | - | - |
| Interest Expense | $2.31M | $357K | $76K | $24K | $0 |
| Interest Income | $0 | $0 | $0 | $0 | $0 |
| Other Income (Expense) | -$3.41M | -$610K | -$76K | -$24K | $44 |
| Income Before Tax (EBT) | -$10.55M | -$6.15M | -$707K | -$599K | -$1.11M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$10.55M | -$6.15M | -$707K | -$599K | -$1.11M |
| Net Income Margin | - | - | - | - | - |
| Supplementary Data | |||||
| EPS | -0.22 | -0.32 | -0.00 | -0.00 | -0.00 |
| Diluted EPS | -0.22 | -0.32 | -0.00 | -0.00 | -0.00 |
| Weighted Average OS | 48.49M | 19.25M | 1.04B | 1.04B | 1.04B |
| EBITDA | -$7.15M | -$5.79M | -$631K | -$574K | -$1.11M |
| EBITDA Margin | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Assets | |||||
| Current Assets | |||||
| Cash and Cash Equivalents | $7.18M | $64K | $3K | $76K | $301K |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $7.18M | $64K | $3K | $76K | $301K |
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $0 | $0 | $0 | $250K | $0 |
| Total Current Assets | $7.29M | $158K | $7K | $330K | $305K |
| Long-Term Assets | |||||
| Property, Plant & Equipment Net | $0 | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $2.3M | $2.3M | $2.19M | $2.21M | $737K |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $0 | $0 |
| Total Long-Term Assets | $2.3M | $2.3M | $2.19M | $2.21M | $737K |
| Other Assets | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $9.59M | $2.46M | $2.19M | $2.54M | $1.04M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | $0 | $64K | $151K | $8K | $15K |
| Short-Term Debt | $0 | $272K | $1.47M | $1.35M | $0 |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $77K | $0 | $0 | -$0 | $0 |
| Total Current Liabilities | $77K | $1.25M | $1.62M | $1.36M | $15K |
| Long-Term Liabilities | |||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $53K | $24K | $0 | $0 | $0 |
| Total Long-Term Liabilities | $53K | $24K | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $130K | $1.27M | $1.62M | $1.36M | $15K |
| Stockholders' Equity | |||||
| Preferred Stock | $0 | $0 | $0 | $505 | $505 |
| Common Stock | $7K | $3K | $2K | $104K | $104K |
| Retained Earnings | -$21.11M | -$10.56M | -$3.92M | -$3.22M | -$2.62M |
| Comprehensive Income & Other | $516K | $0 | $0 | $751K | $0 |
| Other Stockholders' Equity | $30.57M | $11.75M | $4.49M | $4.29M | $3.54M |
| Total Equity | $9.46M | $1.19M | $572K | $1.18M | $1.03M |
| Minority Interest | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $9.59M | $2.46M | $2.19M | $2.54M | $1.04M |
| Supplementary Data | |||||
| Total Debt | $0 | $272K | $1.47M | $1.35M | $0 |
| Net Debt | -$7.18M | $208K | $1.46M | $1.27M | -$301K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Operating Activities | |||||
| Net Income | -$10.55M | -$6.15M | -$707K | -$599K | -$1.11M |
| Depreciation & Amortization | $0 | $0 | $0 | $0 | $0 |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $0 | $2.65M | $0 | $1K | $821K |
| Changes in Working Capital: | |||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | $0 | -$188K | $104K | -$7K | -$13K |
| Other Working Capital | -$922K | $338K | $157K | $5K | $17K |
| Total Working Capital Change | -$922K | $151K | $261K | -$2K | $4K |
| Other Non-Cash Items | $5.62M | $404K | $0 | $0 | $0 |
| Net Cash from Operating | -$5.86M | -$2.95M | -$447K | -$600K | -$284K |
| Investing Activities | |||||
| Capital Expenditures | $0 | -$123K | -$14K | -$125K | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $38K | $0 | $0 |
| Net Cash from Investing | $0 | -$123K | $24K | -$125K | $0 |
| Financing Activities | |||||
| Debt Repaid | -$2.13M | - | - | - | - |
| Common Stock Issuance | $13.51M | $295K | $100K | $750K | $250K |
| Common Stock Repurchases | $0 | -$120K | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$40K | $779K | $91K | -$241K | $0 |
| Net Cash from Financing | $12.97M | $3.13M | $350K | $500K | $250K |
| Forex Effect | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $7.11M | $61K | -$73K | -$225K | -$34K |
| Supplementary Data | |||||
| Operating Cash Flow | -$5.86M | -$2.95M | -$447K | -$600K | -$284K |
| Capital Expenditure | $4 | -$123K | -$14K | -$125K | $0 |
| Free Cash Flow | -$5.86M | -$3.07M | -$461K | -$725K | -$284K |
| Cash at Beginning | $64K | $3K | $76K | $301K | $335K |
| Cash at End | $7.18M | $64K | $3K | $76K | $301K |